| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alternative codon usage of PRRS virus ORF5 gene increases eucaryotic expression of GP5 glycoprotein and improves immune response in challenged pigs
|
Kheyar, Ali
|
|
2005
|
23 |
31 |
p. 4016-4022
7 p.
|
article
|
| 2 |
A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7(11–20) cytotoxic T lymphocyte epitope
|
Schreurs, Marco W.J.
|
|
2005
|
23 |
31 |
p. 4005-4010
6 p.
|
article
|
| 3 |
Editorial Board/Aims and Scope
|
|
|
2005
|
23 |
31 |
p. CO2-
1 p.
|
article
|
| 4 |
Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge
|
Busch, Marc
|
|
2005
|
23 |
31 |
p. 4036-4047
12 p.
|
article
|
| 5 |
Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant
|
DePaz, Roberto A.
|
|
2005
|
23 |
31 |
p. 4029-4035
7 p.
|
article
|
| 6 |
Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P. vivax in Aotus monkeys
|
Barrero, Carlos A.
|
|
2005
|
23 |
31 |
p. 4048-4053
6 p.
|
article
|
| 7 |
Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8–10-year-old children
|
Duval, Bernard
|
|
2005
|
23 |
31 |
p. 4082-4087
6 p.
|
article
|
| 8 |
Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody
|
Patel, J.R.
|
|
2005
|
23 |
31 |
p. 4023-4028
6 p.
|
article
|
| 9 |
Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice
|
Yang, Qiong
|
|
2005
|
23 |
31 |
p. 4088-4096
9 p.
|
article
|
| 10 |
Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains
|
Wareing, Mark D.
|
|
2005
|
23 |
31 |
p. 4075-4081
7 p.
|
article
|
| 11 |
Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
|
Kran, Anne-Marte B.
|
|
2005
|
23 |
31 |
p. 4011-4015
5 p.
|
article
|
| 12 |
Relative efficacy of inactivated bovine herpesvirus-1 (BHV-1) vaccines
|
Patel, J.R.
|
|
2005
|
23 |
31 |
p. 4054-4061
8 p.
|
article
|
| 13 |
The effectiveness of the mumps component of the MMR vaccine: a case control study
|
Harling, Richard
|
|
2005
|
23 |
31 |
p. 4070-4074
5 p.
|
article
|
| 14 |
Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs
|
de Aluja, Aline S.
|
|
2005
|
23 |
31 |
p. 4062-4069
8 p.
|
article
|
Journal description